These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

313 related articles for article (PubMed ID: 33740056)

  • 41. Associations between perfluoroalkyl substances and serum lipids in a Swedish adult population with contaminated drinking water.
    Li Y; Barregard L; Xu Y; Scott K; Pineda D; Lindh CH; Jakobsson K; Fletcher T
    Environ Health; 2020 Mar; 19(1):33. PubMed ID: 32169067
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Genotoxicity assessment of per- and polyfluoroalkyl substances mixtures in human liver cells (HepG2).
    Ojo AF; Peng C; Ng JC
    Toxicology; 2022 Dec; 482():153359. PubMed ID: 36341878
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Prenatal exposure to per- and polyfluoroalkyl substances (PFAS) and associations with attention-deficit/hyperactivity disorder and autism spectrum disorder in children.
    Skogheim TS; Weyde KVF; Aase H; Engel SM; Surén P; Øie MG; Biele G; Reichborn-Kjennerud T; Brantsæter AL; Haug LS; Sabaredzovic A; Auyeung B; Villanger GD
    Environ Res; 2021 Nov; 202():111692. PubMed ID: 34293314
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Associations of perfluoroalkyl and polyfluoroalkyl substances (PFAS) and PFAS mixtures with adipokines in midlife women.
    Ding N; Karvonen-Gutierrez CA; Herman WH; Calafat AM; Mukherjee B; Park SK
    Int J Hyg Environ Health; 2021 Jun; 235():113777. PubMed ID: 34090141
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Associations of Perfluoroalkyl substances with blood lipids and Apolipoproteins in lipoprotein subspecies: the POUNDS-lost study.
    Liu G; Zhang B; Hu Y; Rood J; Liang L; Qi L; Bray GA; DeJonge L; Coull B; Grandjean P; Furtado JD; Sun Q
    Environ Health; 2020 Jan; 19(1):5. PubMed ID: 31931806
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Exposure to per- and polyfluoroalkyl substances and age-related macular degeneration in U.S. middle-aged and older adults.
    Kang H; Park SK; Kim DH; Choi YH
    Chemosphere; 2024 Sep; 364():143167. PubMed ID: 39181460
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Prenatal exposure to per- and polyfluoroalkyl substances (PFAS) and neurobehavior in US children through 8 years of age: The HOME study.
    Vuong AM; Webster GM; Yolton K; Calafat AM; Muckle G; Lanphear BP; Chen A
    Environ Res; 2021 Apr; 195():110825. PubMed ID: 33545124
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Isomers of per- and polyfluoroalkyl substances and uric acid in adults: Isomers of C8 Health Project in China.
    Zeng XW; Lodge CJ; Dharmage SC; Bloom MS; Yu Y; Yang M; Chu C; Li QQ; Hu LW; Liu KK; Yang BY; Dong GH
    Environ Int; 2019 Dec; 133(Pt A):105160. PubMed ID: 31518937
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Temporal trends of perfluoroalkyl acids in plasma samples of pregnant women in Hokkaido, Japan, 2003-2011.
    Okada E; Kashino I; Matsuura H; Sasaki S; Miyashita C; Yamamoto J; Ikeno T; Ito YM; Matsumura T; Tamakoshi A; Kishi R
    Environ Int; 2013 Oct; 60():89-96. PubMed ID: 24013022
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Repeated measurements of per- and polyfluoroalkyl substances (PFASs) from 1979 to 2007 in males from Northern Norway: assessing time trends, compound correlations and relations to age/birth cohort.
    Nøst TH; Vestergren R; Berg V; Nieboer E; Odland JØ; Sandanger TM
    Environ Int; 2014 Jun; 67():43-53. PubMed ID: 24657493
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Per- and polyfluoroalkyl substances (PFAS) and fetal growth: A nation-wide register-based study on PFAS in drinking water.
    Säve-Söderbergh M; Gyllenhammar I; Schillemans T; Lindfeldt E; Vogs C; Donat-Vargas C; Halldin Ankarberg E; Glynn A; Ahrens L; Helte E; Åkesson A
    Environ Int; 2024 May; 187():108727. PubMed ID: 38735074
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Prenatal exposure to per- and polyfluoroalkyl substances and infant growth and adiposity: the Healthy Start Study.
    Starling AP; Adgate JL; Hamman RF; Kechris K; Calafat AM; Dabelea D
    Environ Int; 2019 Oct; 131():104983. PubMed ID: 31284113
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Sociodemographic and behavioral determinants of serum concentrations of per- and polyfluoroalkyl substances in a community highly exposed to aqueous film-forming foam contaminants in drinking water.
    Barton KE; Starling AP; Higgins CP; McDonough CA; Calafat AM; Adgate JL
    Int J Hyg Environ Health; 2020 Jan; 223(1):256-266. PubMed ID: 31444118
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Prenatal exposure to perfluoroalkyl substances and birth outcomes in a Spanish birth cohort.
    Manzano-Salgado CB; Casas M; Lopez-Espinosa MJ; Ballester F; Iñiguez C; Martinez D; Costa O; Santa-Marina L; Pereda-Pereda E; Schettgen T; Sunyer J; Vrijheid M
    Environ Int; 2017 Nov; 108():278-284. PubMed ID: 28917208
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Prenatal perfluoroalkyl substances and newborn anogenital distance in a Canadian cohort.
    Arbuckle TE; MacPherson S; Foster WG; Sathyanarayana S; Fisher M; Monnier P; Lanphear B; Muckle G; Fraser WD
    Reprod Toxicol; 2020 Jun; 94():31-39. PubMed ID: 32283250
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Early-pregnancy plasma per- and polyfluoroalkyl substance (PFAS) concentrations and hypertensive disorders of pregnancy in the Project Viva cohort.
    Preston EV; Hivert MF; Fleisch AF; Calafat AM; Sagiv SK; Perng W; Rifas-Shiman SL; Chavarro JE; Oken E; Zota AR; James-Todd T
    Environ Int; 2022 Jul; 165():107335. PubMed ID: 35696844
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Prenatal Exposures to Perfluoroalkyl Acids and Associations with Markers of Adiposity and Plasma Lipids in Infancy: An Odense Child Cohort Study.
    Jensen RC; Andersen MS; Larsen PV; Glintborg D; Dalgård C; Timmermann CAG; Nielsen F; Sandberg MB; Andersen HR; Christesen HT; Grandjean P; Jensen TK
    Environ Health Perspect; 2020 Jul; 128(7):77001. PubMed ID: 32628516
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Prenatal and childhood exposure to per- and polyfluoroalkyl substances (PFASs) and child cognition.
    Harris MH; Oken E; Rifas-Shiman SL; Calafat AM; Ye X; Bellinger DC; Webster TF; White RF; Sagiv SK
    Environ Int; 2018 Jun; 115():358-369. PubMed ID: 29705692
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Per- and polyfluoroalkyl substances (PFAS) in Australia: Current levels and estimated population reference values for selected compounds.
    Toms LML; Bräunig J; Vijayasarathy S; Phillips S; Hobson P; Aylward LL; Kirk MD; Mueller JF
    Int J Hyg Environ Health; 2019 Apr; 222(3):387-394. PubMed ID: 30898527
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Early Pregnancy Plasma Per- and Polyfluoroalkyl Substances (PFAS) and Maternal Midlife Adiposity.
    Burdeau JA; Stephenson BJK; Chavarro JE; Mahalingaiah S; Preston EV; Hivert MF; Oken E; Calafat AM; Rifas-Shiman SL; Zota AR; James-Todd T
    J Clin Endocrinol Metab; 2024 Sep; ():. PubMed ID: 39235224
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.